secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001964738-24-000040
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum Q3 sales flat at $2.082B; adjusted EPS $1.64, raises FY guidance
--------------------------------------------------------------------------

- GAAP EPS $0.70, adjusted EPS $1.64; operating income $275M GAAP, $475M adjusted.
- Reported sales +0.4% YoY; organic sales +0.3%; MedSurg and HIS led growth.
- Free cash flow $76M; cash from operations $169M.
- Full-year organic sales growth, adjusted EPS, and free cash flow guidance raised.
- CEO cites consecutive outperformance; supply agreement mark-up impacted margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/0001964738-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473824000040/solv-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001964738-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer